World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
62504
World Ranking
3203
National Ranking
39

Overview

Peter Rossing is affiliated with the University of Copenhagen in Denmark and has a significant body of work in the field of medicine, with a focus on endocrinology, diabetes, and metabolism. Their research spans several subfields including cardiology and cardiovascular medicine, nephrology, surgery, and molecular biology.

Their work covers key topics related to diabetes treatment and management, diabetes management and research, hormonal regulation and hypertension, chronic kidney disease and diabetes, pancreatic function and diabetes, blood pressure and hypertension studies, and diet and metabolism studies.

Peter Rossing has contributed to multiple high-impact publications, including recent papers such as:

  • Dapagliflozin in Patients with Chronic Kidney Disease (2020, New England Journal of Medicine)
  • Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes (2020, New England Journal of Medicine)
  • Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022, Diabetes Care)
  • KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2020, Kidney International)
  • 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes (2023, European Heart Journal)

Frequent co-authors collaborating with Rossing include Hiddo J.L. Heerspink, Tine W. Hansen, Luís M. Ruilope, Frederik Persson, and Stefan D. Anker.

Their research has been published extensively in journals such as the Journal of the American Society of Nephrology, Nephrology Dialysis Transplantation, Diabetes, Diabetes Obesity and Metabolism, and Diabetes Care.

Best Publications

  • Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Melanie J. Davies;David A. D’Alessio;Judith Fradkin;Walter N. Kernan

  • Dapagliflozin in Patients with Chronic Kidney Disease

    Hiddo J.L. Heerspink;Bergur V. Stefánsson;Ricardo Correa-Rotter;Glenn M. Chertow

  • Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

    George L Bakris;Rajiv Agarwal;Stefan D Anker;Bertram Pitt

  • Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Melanie J. Davies;Melanie J. Davies;David A. D’Alessio;Judith Fradkin;Walter N. Kernan

  • Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

    Caroline S. Fox;Kunihiro Matsushita;Mark Woodward;Mark Woodward;Henk J.G. Bilo

  • New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

    Lesley A Inker;Nwamaka D Eneanya;Josef Coresh;Hocine Tighiouart

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

    Brad C. Astor;Kunihiro Matsushita;Ron T. Gansevoort;Marije Van Der Velde

  • Diabetic kidney disease

    Merlin C. Thomas;Michael Brownlee;Katalin Susztak;Kumar Sharma

  • KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    Ian H. de Boer;M. Luiza Caramori;Juliana C.N. Chan;Hiddo J.L. Heerspink

  • Diabetes and Hypertension: A Position Statement by the American Diabetes Association

    Ian H. De Boer;Sripal Bangalore;Athanase Benetos;Andrew M. Davis

  • Effect of finerenone on albuminuria in patients with diabetic nephropathy : a randomized clinical trial

    George L Bakris;Rajiv Agarwal;Juliana C Chan;Mark E Cooper

  • Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study

    Peter Rossing;Philip Hougaard;Knut Borch-Johnsen;Hans Henrik Parving

  • Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial

    Peter Gæde;Jens Oellgaard;Jens Oellgaard;Bendix Carstensen;Peter Rossing;Peter Rossing;Peter Rossing

  • Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.

    Peter Hovind;Lise Tarnow;Peter Rossing;Berit Ruud Jensen

  • Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.

    M. A. Gall;P. Rossing;P. Skøtt;P. Damsbo

  • Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension

    Bakhtawar K. Mahmoodi;Kunihiro Matsushita;Mark Woodward;Peter J. Blankestijn

  • Progression of nephropathy in type 2 diabetic patients.

    Kasper Rossing;Per K. Christensen;Per K. Christensen;Peter Hovind;Peter Hovind;Lise Tarnow;Lise Tarnow

  • Progression of diabetic nephropathy

    Peter Hovind;Peter Rossing;Lise Tarnow;Ulla M. Smidt

  • Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

    Bertram Pitt;Gerasimos Filippatos;Rajiv Agarwal;Stefan D Anker

  • Correction: Diabetic kidney disease

    Merlin C. Thomas;Michael Brownlee;Katalin Susztak;Kumar Sharma

Frequent Co-Authors

Lise Tarnow
Lise Tarnow Steno Diabetes Center
Hans-Henrik Parving
Hans-Henrik Parving University of Copenhagen
Hiddo J.L. Heerspink
Hiddo J.L. Heerspink University of Groningen
Harald Mischak
Harald Mischak University of Glasgow
Coen D.A. Stehouwer
Coen D.A. Stehouwer Maastricht University
Per-Henrik Groop
Per-Henrik Groop University of Helsinki
Leif Groop
Leif Groop Lund University
Casper G. Schalkwijk
Casper G. Schalkwijk Maastricht University
Oluf Pedersen
Oluf Pedersen University of Copenhagen
Helen M. Colhoun
Helen M. Colhoun University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean attending traditional medical school. Numerous online programs offer alternative pathways for those interested in healthcare. For instance, nursing programs without TEAS provide flexible options for students who prefer schools that don’t require entrance exams, making it easier to access nursing education.

If you’re interested in the management and operational side of healthcare, consider enrolling in healthcare administration degree programs. These online degrees prepare graduates for leadership roles in hospitals, clinics, and other medical facilities.

For registered nurses aiming to advance their clinical careers, there are ADN to NP programs online that allow you to bridge from an associate’s degree in nursing to a master’s level nurse practitioner qualification—completely online.

Additionally, those focused on preventive medicine and wellness can pursue a bachelor's in nutrition online, gaining the expertise needed to become dietary specialists or nutrition consultants.

These online pathways offer convenient, career-focused alternatives for anyone aiming to make a difference in healthcare.

Best Scientists Citing Peter Rossing

Trending Scientists